Adventitial gene transfer to arterial wall

Area of Science:

• Cardiovascular Research
• Gene Therapy
• Molecular Medicine

Background:

• Vascular gene transfer presents a viable strategy for treating cardiovascular conditions.
• Blood vessels are highly accessible targets for gene therapy applications.
• Temporary gene expression is often sufficient for therapeutic benefit in vascular diseases.

Purpose of the Study:

• To review the current state and potential of vascular gene transfer for cardiovascular diseases.
• To highlight effective gene transfer methods and therapeutic targets in vascular applications.
• To identify areas requiring further investigation for clinical translation.

Main Methods:

• Adenovirus-mediated gene transfer for efficient transgene expression in the arterial wall.
• Gene delivery approaches targeting both the lumen and adventitia of arteries.
• Evaluation of therapeutic effects using various genes and antisense oligonucleotides in animal models.

Main Results:

• Adenoviruses demonstrate high efficiency for transgene expression in the arterial wall.
• Successful gene transfer to human peripheral arteries has been reported.
• Promising therapeutic outcomes observed in restenosis models using genes like VEGF and NOS.

Conclusions:

• Vascular gene transfer, particularly with adenoviruses, holds significant therapeutic promise for cardiovascular diseases.
• Gene delivery to the artery wall can be achieved via lumen or adventitial routes.
• Continued research on gene transfer techniques, vectors, and safety is crucial for clinical application.